source
- OncLive poll shows oncogene-driven NSCLC as top focus for lung cancer abstracts at ASCO 2026OncLive surveyed its LinkedIn and X followers to learn which lung cancer topics will draw the most attention at the 2026 ASCO Annual Meeting in Chicago. The poll asked participants to select the ar…
- Poll Shows Readers Most Excited for PersevERA BC Trial Data at ASCO 2026As the 2026 ASCO Annual Meeting draws near, a recent poll asked oncology readers which breast-cancer abstract they are most looking forward to. Respondents could choose among several late-breaking…